MacroGenics, Inc. (MGNX)
2.04
-0.13
(-5.99%)
USD |
NASDAQ |
Nov 17, 16:00
2.04
0.00 (0.00%)
After-Hours: 20:00
MacroGenics Price to Book Value : 5.181 for Nov. 17, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 16, 2026 | 5.511 |
| November 13, 2026 | 5.587 |
| November 12, 2026 | 5.816 |
| November 11, 2026 | 5.892 |
| November 10, 2026 | 6.146 |
| November 09, 2026 | 5.943 |
| November 06, 2026 | 5.918 |
| November 05, 2026 | 5.638 |
| November 04, 2026 | 5.867 |
| November 03, 2026 | 5.918 |
| November 02, 2026 | 5.918 |
| October 30, 2026 | 6.095 |
| October 29, 2026 | 6.044 |
| October 28, 2026 | 6.273 |
| October 27, 2026 | 6.197 |
| October 26, 2026 | 5.562 |
| October 23, 2026 | 5.714 |
| October 22, 2026 | 9.219 |
| October 21, 2026 | 9.118 |
| October 20, 2026 | 8.864 |
| October 19, 2026 | 8.457 |
| October 16, 2026 | 8.254 |
| October 15, 2026 | 8.559 |
| October 14, 2026 | 8.406 |
| October 13, 2026 | 8.686 |
| Date | Value |
|---|---|
| October 12, 2026 | 9.448 |
| October 09, 2026 | 9.498 |
| October 08, 2026 | 9.016 |
| October 07, 2026 | 9.016 |
| October 06, 2026 | 9.244 |
| October 05, 2026 | 9.575 |
| October 02, 2026 | 9.092 |
| October 01, 2026 | 9.143 |
| September 30, 2026 | 9.803 |
| September 29, 2026 | 5.597 |
| September 28, 2026 | 6.027 |
| September 25, 2026 | 5.552 |
| September 24, 2026 | 5.641 |
| September 23, 2026 | 5.641 |
| September 22, 2026 | 6.116 |
| September 21, 2026 | 6.116 |
| September 18, 2026 | 6.146 |
| September 17, 2026 | 6.131 |
| September 16, 2026 | 6.057 |
| September 15, 2026 | 5.997 |
| September 14, 2026 | 6.235 |
| September 11, 2026 | 5.938 |
| September 10, 2026 | 5.894 |
| September 09, 2026 | 6.101 |
| September 08, 2026 | 6.413 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.280 |
| Alnylam Pharmaceuticals, Inc. | 5.815 |
| Anika Therapeutics, Inc. | 1.255 |
| Savara, Inc. | 8.528 |
| Arrowhead Pharmaceuticals, Inc. | 120.64 |
Price to Book Value Related Metrics
| PS Ratio | 1.142 |
| Price | 2.04 |
| Earnings Yield | -40.84% |
| Market Cap | 130.31M |